Wednesday, January 18, 2023: Life Sciences

Moderna Inc. said its experimental RSV vaccine was 83.7 percent effective in a large clinical trial at lowering the risk of a viral respiratory disease in older adults. The company said it will apply for U.S. approval in the coming months, potentially allowing the...

Wednesday, January 18, 2023: Payers

A new Centers for Disease and Control Prevention (CDC) report shows that fewer individuals had difficulty paying medical costs during the COVID-19 pandemic. According to National Health Interview Surveys, 10.5 million fewer people were in families having problems...

Wednesday, January 18, 2023: Providers

The Biden administration announced two new steps to reduce the inappropriate use of antipsychotic medications and strengthen nursing home safety and transparency. First, the Centers for Medicare & Medicaid Services (CMS) will increase oversight of inappropriate...